L2 Asset Management’s Merck MRK Stock Holding History

L2 Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	8,861 -5,244	-37%	-$614K	0.12%	156
2026 Q1	$1.7M	Sell	14,105 -3,999	-22%	-$462K	0.16%	117
2025 Q4	$1.91M	Buy	18,104 +2,057	+13%	+$193K	0.25%	85
2025 Q3	$1.35M	Buy	16,047 +8,812	+122%	+$726K	0.19%	106
2025 Q2	$573K	Buy	7,235 +1,215	+20%	+$96.6K	0.09%	184
2025 Q1	$540K	Buy	+6,020	New	+$562K	0.11%	146
2024 Q2	–	Sell	-5,687	Closed	-$750K	–	224
2024 Q1	$750K	Buy	5,687 +1,596	+39%	+$197K	0.25%	85
2023 Q4	$446K	Buy	4,091 +4,024	+6,006%	+$418K	0.18%	98
2023 Q3	$691K	Sell	67 -10,752	-99%	-$1.16M	0.33%	77
2023 Q2	$1.25M	Buy	10,819 +1,310	+14%	+$149K	0.61%	53
2023 Q1	$1.01M	Buy	9,509 +6,197	+187%	+$669K	0.56%	55
2022 Q4	$367K	Hold	3,312	–	–	0.23%	90
2022 Q3	$285K	Buy	+3,312	New	+$296K	0.2%	97
2020 Q2	–	Sell	-6,079	Closed	-$446K	–	72
2020 Q1	$446K	Buy	6,079 +648	+12%	+$50.9K	0.5%	53
2019 Q4	$471K	Buy	+5,431	New	+$446K	0.41%	59

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

L2 Asset Management's MRK Position: Q2 2026 in Review

L2 Asset Management reduced its Merck (MRK) stake by 37% in Q2 2026, selling an estimated $614K and leaving 8,861 shares worth $1.14M. The position accounts for 0.12% of the portfolio, ranked #156.

L2 Asset Management first reported a position in MRK in Q4 2019 and has held it in 15 quarters since. The position peaked at $1.91M in Q4 2025. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

L2 Asset Management held 8,861 shares of Merck worth $1.14M as of Q2 2026.
L2 Asset Management sold 5,244 Merck shares in Q2 2026, an estimated $614K.
Merck made up 0.12% of L2 Asset Management's portfolio in Q2 2026, its #156 holding.
L2 Asset Management first reported a position in Merck in Q4 2019 and has held it in 15 quarters since.
L2 Asset Management's Merck position peaked at $1.91M in Q4 2025.
3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on L2 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.